AlphaMark Advisors’s Aspen Aerogels ASPN Stock Holding History

AlphaMark Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,000	Closed	-$16K	–	709
2023 Q4	$16K	Hold	1,000	–	–	0.01%	467
2023 Q3	$9K	Buy	+1,000	New	+$7.1K	﹤0.01%	527

Other funds holding ASPN

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

AlphaMark Advisors's ASPN Position: Q1 2024 in Review

AlphaMark Advisors sold out of Aspen Aerogels (ASPN) in Q1 2024, closing a stake of 1,000 shares — an estimated $16K sold.

AlphaMark Advisors first reported a position in ASPN in Q3 2023 and held it in 2 quarters. The position peaked at $16K in Q4 2023. 167 funds tracked by Wall St. Rank hold ASPN as of Q1 2024.

AlphaMark Advisors reported no remaining Aspen Aerogels position as of Q1 2024 after selling out during the quarter.
AlphaMark Advisors sold 1,000 Aspen Aerogels shares in Q1 2024, an estimated $16K.
AlphaMark Advisors first reported a position in Aspen Aerogels in Q3 2023 and held it in 2 quarters.
AlphaMark Advisors's Aspen Aerogels position peaked at $16K in Q4 2023.
167 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2024.

Based on AlphaMark Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.